CG
TMDX icon

Cutler Group’s Transmedics TMDX Stock Holding History

Cutler Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-700
Closed -$38K – 4342
2023
Q3 		$38K Buy
+700
New +$50.4K ﹤0.01% 1658
2022
Q4 		– Sell
-234
Closed -$9K – 5219
2022
Q3 		$9K Hold
234
– – ﹤0.01% 3216
2022
Q2 		$7K Hold
234
– – ﹤0.01% 3503
2022
Q1 		$6K Sell
234
-2,740
-92% -$49.1K ﹤0.01% 4054
2021
Q4 		$56K Sell
2,974
-3,633
-55% -$91.1K ﹤0.01% 2313
2021
Q3 		$218K Buy
6,607
+4,169
+171% +$127K 0.01% 1298
2021
Q2 		$80K Buy
+2,438
New +$67.6K ﹤0.01% 2064

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Cutler Group's TMDX Position: Q4 2023 in Review

Cutler Group sold out of Transmedics (TMDX) in Q4 2023, closing a stake of 700 shares — an estimated $38K sold.

Cutler Group first reported a position in TMDX in Q2 2021 and held it in 7 quarters. The position peaked at $218K in Q3 2021. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

  • Cutler Group reported no remaining Transmedics position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 700 Transmedics shares in Q4 2023, an estimated $38K.
  • Cutler Group first reported a position in Transmedics in Q2 2021 and held it in 7 quarters.
  • Cutler Group's Transmedics position peaked at $218K in Q3 2021.
  • 248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.